Maa: Armenia
Kieli: englanti
Lähde: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
amoxicillin (amoxicillin trihydrate)
A LAB PHARMACEUTICALS LLC
J01CA04
amoxicillin (amoxicillin trihydrate)
500mg
capsules
(10/1x10/) in blister
Prescription
Registered
2022-08-10
A - L A B P H A R M A C E U P T I C A L S , L L C Address: Kochinyan 13/16 street Yerevan - Armenia Tell: ( +374)11 981000 Web: www.alab.am E-Mail: info@alab.am C O N F I D E N T I A L P a g e 1 2 o f 2 3 1.3 PRODUCT INFORMATION 1.3.1 SPC, LABELING & PACKAGE LEAFLET SPC – SUMMARY OF THE PRODUCT CHARACTERISTICS 1) NAME OF THE MEDICINAL PRODUCT TIAMOX (Amoxicillin Capsules 500 mg) 2) QUALITATIVE AND QUANTITATIVE COMPOSITION TIAMOX (AMOXICILLIN CAPSULES 500 MG) Each hard gelatin capsule contains Amoxicillin Trihydrate Eq. to Amoxicillin ……………….500 mg Excipients…………………….q.s. Approved colours used in empty capsule shell. Gelatin, Erythrosine (E127), Titanium dioxide (E171), Indigotine (E132), Iron oxide yellow (E172), Silica, Bronopol, Sodium Lauryl Sulphate, Glycerin, Purified Water. 3) PHARMACEUTICAL FORM Hard gelatin Capsule 4) CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of infection: Amoxicillin capsules is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1): _Oral indications _ Acute bacterial sinusitis Acute Otitis media Acute streptococcal tonsillitis and pharyngitis Acute exacerbations of chronic bronchitis Community acquired pneumonia Acute cystitis Asymptomatic Bacteriuria in pregnancy Acute pyelonephritis Typhoid and paratyphoid fever Dental abscess with spreading cellulitis Prosthetic joint infections Helicobacter pylori eradication Lyme disease Amoxicillin is also indicated for the prophylaxis of endocarditis Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The dose of Amoxicillin that is selected to treat an individual infection should take into account: The expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4) The severity and the site of the infection A - L A B P H A R M A C E U P T I C A L S , L L C Add Lue koko asiakirja